During those eight years, the clinicians subjectively estimated that healthy hair growth has been maintained in virtually 100% of the people whose goal was to prevent the onset of Follicle Nutrient Deficiency Syndrome (FNDS) and resulting alopecia.
The clinicians estimate that between 80 - 85% of their male patients and upwards of 90% of their female patients being treated for FNDS and seeking hair regeneration therapy have been able to regrow their lost hair. Video testimonials offered by some of these hair regeneration patients are available here: http://www.Biologixhair.com/results/hair-regeneration.
Of the alopecia areata patients - both men and women - the rate of success has been observed to be nearly 100%. Alopecia areata testimonials can be found here: http://www.biologixhair.com/results/alopecia-areata.
Over these eight years, no negative side effects have been reported.
Preparing For Global Commercial Success
Biologix is now ready to make this groundbreaking hair restoration and hair loss prevention therapy available for the first time.
While Biologix Hair Inc., together with wholly owned subsidiary companies operated by Biologix Hair Science Ltd., works to obtain FDA approval and subsequent approvals in major markets, Biologix has simultaneously been developing a global distribution network of licensed clinicians and medical practitioners seeking to become Certified Biologix Hair Therapists and secure exclusive territorial purchasing and treatment rights for the Biologix Hair Therapy System.
Although the Biologix Hair Therapy System is currently not able to be offered in more heavily regulated markets, such as the United States, Canada and the European Union, there are several countries and regions with less restrictive regulatory barriers that enable Biologix to accelerate the regulatory approval process and initiate the availability of treatment via its rapidly expanding international network of certified clinicians - Colombia being one of them. And that is where the Company will headquarter its initial fee-for-service operations. At this time, the Company will actively market only to citizens in such areas and will not market to or encourage travel by citizens of regions where the Biologix Hair Therapy System has not yet been approved by regulatory agencies.
Growing Revenues Through Our Licensed Clinician Network
The Colombia-based clinic will utilize the same Biologix Revive formula and techniques employed by treatment clinicians during the pre-clinical trials that were carried out by the original inventor group.
Upon completion of the standardization work currently well underway with the Beijing Institute of Technology (BIT) and the filing of our final formulation with the US Patent and Trademark Office, Biologix should be ready to start utilizing the standardized vials in its prototype clinic and be ready to commence shipment of Biologix Revive to licensed clinics operating in less regulated markets where regulatory approvals are obtainable.
Biologix management is currently working together with its Medical Advisory Board and its team of legal advisors to determine in which strategic locations around the world to allow Certified Biologix Hair Therapists to begin offering commercial treatment options - expected to begin before the end of the first quarter of 2014.
Most Popular Stories
- Hezbollah Chief's Assassination Claimed by Sunni Group
- U.S. Growth Stayed Steady During Shutdown, Fed Says
- Allstate Seeks to Invest in Minority Firms
- Newtown Massacre Heard on 911 Recordings
- SpaceX's Satellite Launch Is 'Game-Changer'
- Latin Music Conference Turns 25
- Climate Change Early Warning System Urged
- Guardian Pressured to Stop NSA Stories: Editor
- New Home Sales Shoot up 25 Percent in October
- Reid Confident Congress to Pass Immigration Bill